2026 Spring Cohort Articles

What does it take to restore heart function to heart failure patients? Vectorial Corporation is on a mission to find out. They aim to grow their business and develop brand new gene therapy for restoring a troubled heart’s vitality.

Cultivating a small-molecule therapy that can modulate immune signaling pathways is the goal of S1P Therapeutics. Their aim is to treat chronic kidney disease and other serious conditions, and they’ll be pursuing this goal as they grow through the Spring 2026 Cohort.

When you need a random number generator, you want it to be fast, cost-efficient, and secure. Randao.net is building a decentralized randomness protocol to offer a true alternative for blockchain platform and smart contract apps.

Optimizing clean hydrogen production is the name of the game for Helix Hydrogen, Inc. While undergoing the Spring 2026 Cohort, Helix Hydrogen will work towards solving the problems of efficiency, affordability, and scalability in hydrogen production.